Effects of oseltamivir treatment of index patients with influenza on secondary household illness in an urban setting in Bangladesh: secondary analysis of a randomised, placebo-controlled trial.

Author: AzimTasnim, BarnesJohn, BreseeJoseph, BrooksW Abdullah, FryAlicia M, GoswamiDoli, GubarevaLarisa, LubyStephen P, NaharKamrun, RahmanMustafizur, SharminAmina T, TrujilloAlma

Paper Details 
Original Abstract of the Article :
Antiviral drugs are a proposed medical intervention to reduce household transmission of influenza viruses. In a previously described randomised, placebo-controlled trial in Dhaka, Bangladesh, we showed that oseltamivir treatment of index patients was able to reduce influenza symptom duration and vir...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/S1473-3099(15)70041-1

データ提供:米国国立医学図書館(NLM)

Oseltamivir: A Shield Against the Desert Wind of Influenza Transmission

Influenza, a common respiratory illness, can spread like a desert wind, threatening to sweep through communities. This study investigates the potential of oseltamivir, an antiviral medication, to reduce the spread of influenza within households.

The researchers conducted a randomized, placebo-controlled trial in Bangladesh, evaluating the effectiveness of oseltamivir in reducing influenza symptom duration and virus shedding in index patients (the first person in a household to become ill). The study found that oseltamivir treatment was associated with a reduction in symptom duration and viral shedding in index patients. The authors' findings suggest that oseltamivir treatment could potentially limit the spread of influenza within households, helping to protect vulnerable individuals.

Preventing the Spread: Building a Wall Against the Desert Wind

The study's findings provide encouraging evidence for the potential of oseltamivir to reduce influenza transmission within households. The researchers' work highlights the importance of prompt treatment and antiviral medications in limiting the spread of this contagious illness. The findings suggest that oseltamivir could play a vital role in protecting vulnerable individuals, such as young children and older adults, from the debilitating effects of influenza.

Protecting Our Communities: Creating a Haven from the Desert Wind

This research underscores the importance of public health efforts to mitigate the spread of infectious diseases. The authors' findings highlight the potential of antiviral medications, like oseltamivir, to help protect vulnerable individuals and communities from the onslaught of influenza. By working together to promote vaccination, encourage early treatment, and implement effective public health measures, we can help create a more resilient society, offering a haven from the desert winds of infectious disease.

Dr. Camel's Conclusion

This study is a valuable contribution to our understanding of influenza transmission and the potential of antiviral medications to protect communities. The authors' findings offer a glimmer of hope for preventing the spread of this debilitating illness, reminding us that collective efforts can make a significant difference in safeguarding our health and well-being.

Date :
  1. Date Completed 2015-08-03
  2. Date Revised 2016-06-20
Further Info :

Pubmed ID

25788164

DOI: Digital Object Identifier

10.1016/S1473-3099(15)70041-1

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.